Onyia Jude, Chief Scientific Officer at Neurocrine Biosciences ($NBIX), made two open market sales of company stock over the past year, totaling about $10.5 million. His most recent sale occurred on July 9, 2025. These sales rank 1,085th among 11,678 individual insiders, above the average sale amount of $8.6 million and below the average of 6.4 transactions per insider. Jude reported no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | G | Common Stock | 3110 | $0.00 | 25,670.0000 | 102,500,000 | 10.81% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | F | Common Stock | 1466 | $124.12 | 19,600.0000 | 102,500,000 | 6.96% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | F | Common Stock | 10755 | $124.12 | 28,780.0000 | 102,500,000 | 27.20% | 0.01% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | A | Common Stock | 19935 | $0.00 | 39,535.0000 | 102,500,000 | 101.71% | 0.02% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2717 | $0.00 | 21,066.0000 | 102,500,000 | 14.81% | 0.00% |
| Feb. 12, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2560 | $0.00 | 18,537.0000 | 102,500,000 | 16.02% | 0.00% |
| Feb. 12, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | F | Common Stock | 1426 | $123.10 | 17,111.0000 | 102,500,000 | 7.69% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2690 | $0.00 | 19,801.0000 | 102,500,000 | 15.72% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | F | Common Stock | 1452 | $124.12 | 18,349.0000 | 102,500,000 | 7.33% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | A | Restricted Stock Unit | 9669 | $0.00 | 9,669.0000 | 102,500,000 | 9999.99% | 0.01% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | A | Stock Option | 55119 | $0.00 | 55,119.0000 | 102,500,000 | 9999.99% | 0.05% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2717 | $0.00 | 2,717.0000 | 102,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2690 | $0.00 | 5,380.0000 | 102,500,000 | 33.33% | 0.00% |
| Feb. 12, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2560 | $0.00 | 7,681.0000 | 102,500,000 | 25.00% | 0.00% |
| Jan. 31, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 238 | $0.00 | 16,119.0000 | 102,500,000 | 1.50% | 0.00% |
| Jan. 31, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | F | Common Stock | 142 | $136.06 | 15,977.0000 | 102,500,000 | 0.88% | 0.00% |
| Jan. 31, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 238 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Nov. 29, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 4426 | $0.00 | 18,129.0000 | 102,500,000 | 32.30% | 0.00% |
| Nov. 29, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 4426 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Nov. 29, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | F | Common Stock | 2248 | $152.16 | 15,881.0000 | 102,500,000 | 12.40% | 0.00% |
| Sept. 3, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | G | Common Stock | 1470 | $0.00 | 13,703.0000 | 103,700,000 | 9.69% | 0.00% |
| Aug. 5, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | G | Common Stock | 3116 | $0.00 | 15,173.0000 | 103,700,000 | 17.04% | 0.00% |
| July 9, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Non-Qualified Stock Option | 59819 | $0.00 | 35,268.0000 | 103,700,000 | 62.91% | 0.06% |
| July 9, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 59819 | $130.46 | 18,289.0000 | 103,700,000 | 76.58% | 0.06% |
| July 9, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 59819 | $84.74 | 78,108.0000 | 103,700,000 | 327.08% | 0.06% |
| July 2, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 20362 | $130.13 | 18,289.0000 | 103,700,000 | 52.68% | 0.02% |
| July 2, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Non-Qualified Stock Option | 20362 | $0.00 | 95,087.0000 | 103,700,000 | 17.64% | 0.02% |
| July 2, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 20362 | $84.74 | 38,651.0000 | 103,700,000 | 111.33% | 0.02% |
| June 3, 2025 | Voyager Therapeutics, Inc. | $VYGR | Onyia Jude | Director | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 58,349,769 | 9999.99% | 0.04% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2690 | $0.00 | 8,070.0000 | 103,700,000 | 25.00% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2717 | $0.00 | 18,278.0000 | 103,700,000 | 17.46% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 1432 | $116.83 | 16,846.0000 | 103,700,000 | 7.83% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2690 | $0.00 | 19,536.0000 | 103,700,000 | 15.97% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 1447 | $116.75 | 18,089.0000 | 103,700,000 | 7.41% | 0.00% |
| Feb. 12, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | A | Stock Option | 54645 | $0.00 | 54,645.0000 | 103,700,000 | 9999.99% | 0.05% |
| Feb. 12, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | A | Restricted Stock Unit | 10241 | $0.00 | 10,241.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2717 | $0.00 | 5,434.0000 | 103,700,000 | 33.33% | 0.00% |
| Jan. 31, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 126 | $152.97 | 15,561.0000 | 103,700,000 | 0.80% | 0.00% |
| Jan. 31, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 238 | $0.00 | 15,687.0000 | 103,700,000 | 1.54% | 0.00% |
| Jan. 31, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 238 | $0.00 | 238.0000 | 103,700,000 | 50.00% | 0.00% |
| Nov. 29, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 2331 | $126.29 | 15,449.0000 | 104,300,000 | 13.11% | 0.00% |
| Nov. 29, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 4426 | $0.00 | 4,426.0000 | 104,300,000 | 50.00% | 0.00% |
| Nov. 29, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | M | Common Stock | 4426 | $0.00 | 17,780.0000 | 104,300,000 | 33.14% | 0.00% |
| June 5, 2024 | Voyager Therapeutics, Inc. | $VYGR | Onyia Jude | Director | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 57,117,046 | 9999.99% | 0.04% |
| Feb. 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 1432 | $132.94 | 13,128.0000 | 101,000,000 | 9.84% | 0.00% |
| Feb. 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | A | Stock Option | 54069 | $0.00 | 54,069.0000 | 101,000,000 | 9999.99% | 0.05% |
| Feb. 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | A | Restricted Stock Unit | 10760 | $0.00 | 10,760.0000 | 101,000,000 | 9999.99% | 0.01% |
| Jan. 31, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 126 | $141.94 | 11,843.0000 | 101,000,000 | 1.05% | 0.00% |
| Nov. 29, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 2331 | $113.57 | 11,732.0000 | 98,900,000 | 16.58% | 0.00% |
| Aug. 21, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 3198 | $107.37 | 9,638.0000 | 98,900,000 | 24.91% | 0.00% |
| June 6, 2023 | Voyager Therapeutics, Inc. | $VYGR | Onyia Jude | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 42,161,326 | 9999.99% | 0.05% |
| Feb. 23, 2023 | Voyager Therapeutics, Inc. | $VYGR | Onyia Jude | Director | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 38,356,810 | 9999.99% | 0.11% |
| Feb. 13, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | A | Stock Option | 67541 | $0.00 | 67,541.0000 | 98,900,000 | 9999.99% | 0.07% |
| Feb. 13, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | A | Restricted Stock Unit | 10868 | $0.00 | 10,868.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 4508 | $102.30 | 6,525.0000 | 98,900,000 | 40.86% | 0.00% |
| Jan. 31, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Onyia Jude | Chief Scientific Officer | S | Common Stock | 126 | $108.48 | 2,477.0000 | 98,900,000 | 4.84% | 0.00% |